患者对电子处方系统的看法,经验和满意度:一个横截面研究
Jahanpour Alipour1, Roxana Sharifian2, Javid Dehghan Haghighi3
1Health Human Resources Research Center, School of Health Management and Information Sciences, Department of Health Information Management, Shiraz University of Medical Sciences, Shiraz, Iran.
International journal of medical informatics
|November 12, 2023
概括
大多数伊朗患者都知道并更喜欢电子处方系统 (e-prescribing). 虽然满意度通常是积极的,但专注于患者需求可以增强这种强制性的医疗保健技术.
科学领域:
- 医疗信息学 医疗信息学
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 电子处方 (e-prescribing) 系统为医疗保健质量和降低成本提供了潜在的好处.
- 自2021年12月以来,电子处方已成为伊朗的强制性系统.
- 了解患者的看法对于成功实施电子处方至关重要.
研究的目的:
- 调查患者对伊朗强制性电子处方系统的看法.
- 评估患者的满意度,态度和电子处方对护理的感知影响.
主要方法:
- 在2023年进行了一项描述性-分析性横截面研究,涉及来自五所教学医院的394名患者.
- 数据采集使用研究人员制作的问卷.
- 统计分析包括描述性统计和推断测试 (皮尔森,斯皮尔曼,ANOVA,t测试).
主要成果:
- 大约85%的患者知道电子处方系统,70%的人更喜欢它.
- 平均患者满意度和态度分数分别为3.91/5和3.45/5.
- 在对患者护理的感知影响和患者对电子处方的态度之间发现了显著的相关性.
结论:
- 大多数患者都知道并更喜欢电子处方系统,报告了积极的整体满意度.
- 基于短信的跟踪代码是患者最喜欢的处方跟踪方法.
- 提高以患者为中心的护理需要更大的患者参与,并在电子处方系统中考虑他们的需求.
相关概念视频
01:30Methods of Documentation VII: EMR
840
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
840
01:15Nursing Evaluation
3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
01:19Pharmacovigilance
860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860
01:21Methods of Documentation III: PIE
1.4K
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
1.4K
01:17Assessment of the Gastrointestinal System I: Subjective Data
202
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
202
01:24Factors Influencing Drug Absorption: Presystemic Elimination
233
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
233